• 6 results in Exploration of Neuroprotective Therapy
    Sort by
    Most Cited
    Open Access
    Review
    Neurological complications during HIV infection
    Early in the course of infection, human immunodeficiency virus (HIV) is able to enter the central nervous system where it stablishes a permanent reservoir. Current antiretroviral therapies do not ef...
    Jose M. Martinez-Navio
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:19-32
    DOI: https://doi.org/10.37349/ent.2021.00004
    View:495
    Download:58
    Open Access
    Editorial
    Science plus technology to address challenges in determining the efficacy of neuroprotective/neurorestorative therapies
    Rafael Franco
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:1-6
    DOI: https://doi.org/10.37349/ent.2021.00001
    View:727
    Download:19
    Times Cited: 0
    Open Access
    Letter to the Editor
    P2X7 receptor involvement in COVID-19 disease
    Peter Illes
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:7-9
    DOI: https://doi.org/10.37349/ent.2021.00002
    View:277
    Download:23
    Times Cited: 0
    Open Access
    Review
    Cholesterol in autism spectrum disorders
    The autism spectrum disorder (ASD) comprises a series of neurological diseases that share serious alterations of the development of the central nervous system. The degree of disability may vary so t...
    Rafael Franco ... Irene Reyes-Resina
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:10-18
    DOI: https://doi.org/10.37349/ent.2021.00003
    This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
    View:652
    Download:56
    Times Cited: 0
    Open Access
    Review
    Gut microbial imbalance and neurodegenerative proteinopathies: from molecular mechanisms to prospects of clinical applications
    The pathogenic basis behind some of the most prevalent neurodegenerative diseases in advanced societies, known as proteinopathies, deals with alterations in protein homeostasis. Despite the broad di...
    Paula Alonso-García ... Eva Martínez-Pinilla
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:33-54
    DOI: https://doi.org/10.37349/ent.2021.00005
    View:485
    Download:35
    Times Cited: 0
    Open Access
    Review
    Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry
    Since the identification and cloning of the cannabinoid receptor 2 (CB2R), several studies focused on the characterization of its physiological and pathological role. Initially, CB2R was considered ...
    María S. García-Gutiérrez ... Jorge Manzanares
    Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:55-71
    DOI: https://doi.org/10.37349/ent.2021.00006
    View:384
    Download:31
    Times Cited: 0